Adoption of telehealth services has surged in the pandemic – with usage 38 times since January 2020, according to a report from McKinsey. While much attention has been paid to companies building the communication layer between consumers and practitioners, there is also a wave of companies building Device To expand what can be monitored and addressed in the telehealth environment.
In one of the latest developments, Mute – A Tokyo-headquartered healthcare startup that has created a lab-grade testing tool that can be used for at-home diagnosis that translates into actionable health data Raised $3.2 million. The seed round will be used to launch Bisu Body Coach, a portable home health lab that provides personalized nutrition and lifestyle advice through easy, accurate urine and saliva testing. The seed funding raises its total amount to $4.3 million.
The latest funding was led by Tractor, with the participation of ASICS Ventures Corporation, 15th Rock Ventures, Pacifico Investments and SOSV. Athletic footwear giant ASICS is a strategic supporter, and it plans to collaborate with Bisu on health and fitness services initiatives. Co-founder and CEO Daniel Maggs told Nerdshala that Bisu is in discussions with other companies for additional partnerships in the fitness, pet care and bathroom areas.
BISU was established in 2015 and started business in 2017 when it entered into HAX Accelerator Program.
The Bisu Body Coach works around a disposable test stick and a reader that syncs with a smartphone application. The disposable test stick enables users to measure a range of biomarkers in just two minutes using microfluidic “lab-on-a-chip” technology.
Microfluidic “lab-on-a-chip” technology uses spectrometry and real-time end-to-end measurements to eliminate the measurement time issue of traditional test strips. It manipulates a sample such as blood, urine, saliva or sweat inside a small channel to perform a chemical or biological process.
Asked about its differences from other competitors that use lab-on-a-chip technology, Bisu said it focuses on simultaneous testing of multiple biomarkers that can help the user adjust their diet and lifestyle without seeing a doctor. Enables us to understand and make positive changes. . Others typically detect individual biomarkers of high importance such as COVID-19 and influenza that can guide the user to seek help from a physician.
Bisu’s app provides feedback on key nutrition indicators such as hydration, minerals, vitamins, pH, uric acid and ketones. Based on users’ goals, preferences, activity, sleep and weight, Bisu Body Coach provides personalized recommendations. Bisu plans to add zinc and vitamin B measurements in the future and hopes to release a pet health test kit for cats and dogs.
Bisu Body Coach is currently in beta testing in the US and EU. The company aims to commercialize it in these markets in 2022, Maggs said, adding that it is also laying the foundation to enter Asian markets such as Japan and Korea in 2023.
Its main R&D and production team is located in Tokyo, and Bisu’s software and marketing team is based in the US.
Maggs said the traditional at-home diagnostics market, which is primarily dominated by patients, is projected to Nearly $5 billion and growing.
But the potential market for Bisu’s at-home testing also lies with non-patients—people who aren’t under the supervision of physicians or others for a particular thing, but want to learn more about what’s going on inside their bodies. are interested in. Mags said the market for non-patient, at-home diagnostics is currently worth about $10 billion.